Page last updated: 2024-08-16

rivastigmine and pyrimidinones

rivastigmine has been researched along with pyrimidinones in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, YD; Luo, HB; Wu, D; Wu, XN; Wu, Y; Yu, YF; Zhang, C; Zhou, Q	1

Other Studies

1 other study(ies) available for rivastigmine and pyrimidinones

Article	Year
Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease. ACS chemical neuroscience, 2017, 11-15, Volume: 8, Issue:11 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Peptide Fragments; Phosphodiesterase Inhibitors; Protein Aggregation, Pathological; Protein Conformation; Pyrazolones; Pyrimidinones; Rivastigmine	2017

Article

Year

Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.

ACS chemical neuroscience, 2017, 11-15, Volume: 8, Issue:11

Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Peptide Fragments; Phosphodiesterase Inhibitors; Protein Aggregation, Pathological; Protein Conformation; Pyrazolones; Pyrimidinones; Rivastigmine

2017